Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Ovarian Neoplasms

morpholinoanthracycline mx2 has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bämmler, TK; Duran, GE; Kühl, JS; Lau, DH; Lewis, AD; Sikic, BI	1

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Ovarian Neoplasms

Article	Year
Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:3 Topics: Antibiotics, Antineoplastic; Carcinoma; Carubicin; DNA; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured	1996

Article

Year

Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues.

Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:3

Topics: Antibiotics, Antineoplastic; Carcinoma; Carubicin; DNA; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured

1996